Hält derzeit Positionen bei ESSA Pharma Inc, Five Prime Therapeutics Inc, Atreca Inc, Proteostasis Therapeutics Inc and Kezar Life Sciences Inc
Position | Company | Period |
---|---|---|
Director | ESSA Pharma Inc | 1. Januar 2016 - |
Independent Director | Five Prime Therapeutics Inc | 1. September 2010 - |
Independent Director | Atreca Inc | 1. Oktober 2014 - |
Independent Director | Proteostasis Therapeutics Inc | 1. Februar 2016 - |
Independent Director | Kezar Life Sciences Inc | 1. November 2016 - |
Independent Director | Immune Design Corp | 1. März 2014 - 2. April 2019 |
Independent Director | ESSA Pharma Inc | 5. März 2015 - 1. Januar 2016 |
Independent Director | Seagen Inc | 1. Juni 2004 - 16. Mai 2014 |
Director | Lineage Cell Therapeutics Inc | 13. Mai 2013 - 21. März 2014 |
Director | Asterias Biotherapeutics Inc | 1. Juni 2013 - 21. März 2014 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-11-22 | 2023-11-21 |
ESSA Pharma Inc
(EPIX)
|
K Kauf |
23.259
+3.1%
5,73133.274 USD |
23.259 +3.1% | 5,73 | 133.274 USD | |
2023-11-16 | 2023-11-03 |
ESSA Pharma Inc
(EPIX)
|
K Kauf |
16.471
+2.2%
5,9998.661 USD |
16.471 +2.2% | 5,99 | 98.661 USD | |
2023-01-05 | 2022-12-21 |
ESSA Pharma Inc
(EPIX)
|
V Verkauf |
34.334
-4.8%
2,4283.088 USD |
34.334 -4.8% | 2,42 | 83.088 USD | |
2023-01-05 | 2022-12-21 |
ESSA Pharma Inc
(EPIX)
|
V Verkauf |
37.889
-5.0%
2,4191.312 USD |
37.889 -5.0% | 2,41 | 91.312 USD | |
2023-01-05 | 2022-12-20 |
ESSA Pharma Inc
(EPIX)
|
V Verkauf |
43.617
-5.5%
2,53110.351 USD |
43.617 -5.5% | 2,53 | 110.351 USD | |
2023-01-05 | 2022-12-16 |
ESSA Pharma Inc
(EPIX)
|
V Verkauf |
50.000
-5.9%
2,67133.500 USD |
50.000 -5.9% | 2,67 | 133.500 USD | |
2023-01-05 | 2022-12-15 |
ESSA Pharma Inc
(EPIX)
|
V Verkauf |
50.000
-5.6%
2,86143.000 USD |
50.000 -5.6% | 2,86 | 143.000 USD | |
2023-01-05 | 2022-12-15 |
ESSA Pharma Inc
(EPIX)
|
V Verkauf |
32.000
-3.4%
2,9092.800 USD |
32.000 -3.4% | 2,90 | 92.800 USD | |
2023-01-05 | 2022-12-14 |
ESSA Pharma Inc
(EPIX)
|
V Verkauf |
25.000
-2.6%
3,0075.000 USD |
25.000 -2.6% | 3,00 | 75.000 USD | |
2022-11-23 | 2022-11-22 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
77.000
+8.3%
8,27636.790 USD |
77.000 +8.3% | 8,27 | 636.790 USD | |
2022-11-23 | 2022-11-21 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
45.000
+5.1%
7,80351.000 USD |
45.000 +5.1% | 7,80 | 351.000 USD | |
2022-11-15 | 2022-11-14 |
Atea Pharmaceuticals Inc
(AVIR)
|
V Verkauf |
16.166
-2.0%
5,1683.352 USD |
16.166 -2.0% | 5,16 | 83.352 USD | |
2022-11-15 | 2022-11-11 |
Atea Pharmaceuticals Inc
(AVIR)
|
V Verkauf |
25.500
-3.1%
5,15131.333 USD |
25.500 -3.1% | 5,15 | 131.333 USD | |
2022-11-14 | 2022-11-08 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
42.881
+5.1%
5,83249.996 USD |
42.881 +5.1% | 5,83 | 249.996 USD | |
2022-03-22 | 2022-03-21 |
Kezar Life Sciences Inc
(KZR)
|
K Kauf |
20.000
+2.3%
14,77295.400 USD |
20.000 +2.3% | 14,77 | 295.400 USD | |
2022-03-22 | 2022-03-18 |
Kezar Life Sciences Inc
(KZR)
|
K Kauf |
45.000
+5.4%
17,00765.000 USD |
45.000 +5.4% | 17,00 | 765.000 USD | |
2022-03-22 | 2022-03-18 |
Kezar Life Sciences Inc
(KZR)
|
K Kauf |
15.000
+1.9%
15,96239.400 USD |
15.000 +1.9% | 15,96 | 239.400 USD | |
2021-04-27 | 2021-04-23 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
5.000
+4.2%
15,7878.900 USD |
5.000 +4.2% | 15,78 | 78.900 USD | |
2021-04-27 | 2021-04-23 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
120.000
+inf%
17,002.040.000 USD |
120.000 +inf% | 17,00 | 2.040.000 USD | |
2021-03-04 | 2021-02-22 |
ESSA Pharma Inc
(EPIX)
|
K Kauf |
57.000
+6.3%
27,001.539.000 USD |
57.000 +6.3% | 27,00 | 1.539.000 USD | |
2020-11-03 | 2020-11-03 |
Atea Pharmaceuticals Inc
(AVIR)
|
K Kauf |
41.666
+5.4%
24,00999.984 USD |
41.666 +5.4% | 24,00 | 999.984 USD | |
2020-06-11 | 2020-06-11 |
Kezar Life Sciences Inc
(KZR)
|
K Kauf |
100.000
+14.6%
5,50550.000 USD |
100.000 +14.6% | 5,50 | 550.000 USD | |
2020-02-05 | 2020-02-04 |
Kezar Life Sciences Inc
(KZR)
|
K Kauf |
120.846
+21.5%
2,60314.200 USD |
120.846 +21.5% | 2,60 | 314.200 USD | |
2013-08-22 | 2013-08-20 | K Kauf |
500
+inf%
3,711.855 USD |
500 +inf% | 3,71 | 1.855 USD |